Advanced Oncotherapy Plc

0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 5.25 697,654 11:07:40
Bid Price Offer Price High Price Low Price Open Price
5.00 5.50 5.26 5.25 5.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Agents & Mgrs 0.00 -29.49 -6.50 - 23.71
Last Trade Time Trade Type Trade Size Trade Price Currency
15:01:00 O 922 5.005 GBX

Advanced Oncotherapy (AVO) Latest News

Advanced Oncotherapy (AVO) Discussions and Chat

Advanced Oncotherapy (AVO) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Advanced Oncotherapy (AVO) Top Chat Posts

Top Posts
Posted at 25/5/2023 09:40 by daijavu
Mark Plesko of Cosylab who seem to be providing software (control system for a linear accelerator) to Advanced Oncotherapy under a Development Agreement has acquired a stack of free AVO shares, instead of a cash payment, in return for Cosylab delivering the control system to AVO.

It seems that Mark Plesko has some faith in the LIGHT system and AVO haven't run out of ideas for keeping the show on the road.

Posted at 04/5/2023 19:33 by kinwah
Nice to see the board has announced the change in registered office to Harley Street after I mentioned it on 1st April. I wonder how many shorts are remaining after the possible bid situation encouraged those with large short positions to reduce their exposure. Quite a cunning plan to drive the share price up and maybe attract some funding. If you look at the terms of the financing under the loan note agreement it grabs quite a lot of the remaining value in the business if I understand it right. Anyone still holding the shares must have bucketloads of optimism.
Posted at 02/4/2023 17:30 by kinwah
Gerhart, the only chance of issuing new equity would be to accompany it with a restructuring of the share capital to convert the existing 25p shares to say a new ordinary share of 0.1p and a deferred share of 24.9p. It may be that some holders may think this would remove some support to the share price. We should know soon what will happen next.
Posted at 28/3/2023 08:00 by daijavu
From how AVO seems to work, they outsource production. They don't make many, or any, components themselves. What they've done up to now is focus on the final assembly. That means that volume ought not to be an issue. Cost could be taken care of by building to order, in which case the purchasers pay the costs of production before they get the machine. AVO have already calculated the selling price and their anticipated profit so I assume the difference is their anticipated cost of production. To get to those figures they must have agreements in place in which the manufacturers of the components provide AVO with their cost of production figures. AVO doesn't have any factories outside of Daresbury because they won't need them.

They seem to be planning to be an asset light company, a bit like Apple and Microsoft who don't actually make anything themselves. They outsource everything and get paid a lot of money for selling it all to you and me.

I anticipate that AVO might be similar. All they need to do now is get over their present financial difficulties.

Posted at 27/3/2023 08:37 by daijavu
red hook.
While I'm not impressed by the BoD, I hope you're wrong. The AVO share price has been here before but AVO survived.

It's an unusually tight spread this morning and the first trades are buys

Posted at 26/3/2023 19:43 by red rook
... not a holder here, but have been following events over the years
... agree the technology is great but certainly not the BoD
... would appear they are intentionally driving AVO into the ground
... it will be picked up cheap in a fire sale, or after administration

... regarding ''if AVO folds, ... be unfortunate for AVO shareholders and for the scientific members of the AVO BoD''

... no need to worry about the BoD :-)
... on AIM, not all shareholders are created equal, irrespective of what the rules say
... it will certainly be unfortunate for the retail shareholders
... but the BoD will negotiate themselves a good deal what ever happens, or whoever takes over.
... it's a shame but that's the reality
... maybe that's why the BoD appear to be so laid back about the unfolding train crash

Posted at 26/3/2023 00:49 by daijavu
Most of the risk has now been removed and we are close to AVO making money. My main concern is that while LIGHT will undeniably be a success it might not be with AVO.

I believe that CERN still holds the rights to LIGHT so that if AVO folds, LIGHT could be licenced by CERN to another company. That would be unfortunate for AVO shareholders and for the scientific members of the AVO BoD who helped develop LIGHT from its early days under CERN a decade or more ago. Before AVO existed.

My view is that LIGHT makes AVO different from most other AIM companies and CERN's interest in LIGHT makes it more different still.

But what do I know?

Posted at 02/3/2023 09:55 by gerhart
I'm in at a much higher price. Bought some, at what now seems a completely stupid level. Then plenty more around 40p.

But I can't say the warning signals weren't there to enable me to get out at a loss before this level. ...the constant, almost monthly, passing around of the hat, raising more funds, with no clear long term financial plan provided. Then the inevitable, perhaps unavoidable, tech delays.

Yesterday's announcement still has a "headline" of 25p. So perhaps whatever way things work out, that will be the guide to final fundraising, so may see the share price return to at least that level in due course. We'll see.

First human due to be treated in later this year. And with them so far down the road, I agree with others, though poor business managers, good medics/scientists. So I think we'll make it through. Just how bad will any "dilution" be? We'll see in due course the plans.

Posted at 01/3/2023 11:10 by gerhart
At end of Dec most/all key directors bought shares around 12p. Just a few weeks later they issue financial plans. Share price goes on major slide.

So did the directors buy, knowing any placing/rights (along with any financial loans) will be well above 12p.

Or did they buy to give the impression, that they were suffering too, knowing share price would take a hit on speculation once the plans were announced - which they must have known general intentions when they bought.

I think and hope it is the former. All those big investors that stumped up big sums previously must have known the long term risk/plans for final funds to bring Tech to fruition. So wouldn't have stumped-up just to watch their investment collapse.

So this share price slide is due to negative speculation only? That's my hope.

(happened, justifiably, before when they got into the death spiral shares for loans. Shares dumped. Price fell. Even greater shares for loans. Shares dumped, price fell...etc etc. Then they changed track, and their was massive spike)

Posted at 03/8/2022 09:09 by daijavu
Does anyone remember AVO's massive reverse split of 2016?

The share price had been hovering around 20p for quite a while when the BoD announced their brilliant plan to make the share price 'easier to understand'. They cut everyone's share holding by 25 times. so that if you owned, say, 1,000 shares before the reverse split, you suddenly owned just 40 shares after it. But the share price immediately went up to £5 a share so you didn't lose any money. Not at first. The BoD then went on to gradually increase the number of shares through fund raisings, causing massive dilutions that have brought the share price back down to around 20p.

I wonder what they'll do next?

Advanced Oncotherapy share price data is direct from the London Stock Exchange
Your Recent History
Advanced O..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230609 14:31:56